SCHEMBL9939438

SCHEMBL9939438

CC(C)(C)c1ccc(C2C(=O)CCC2c2ccc(NC(=O)O)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER2 P43116 1/20 0.47
EPHX2 P34913 2/20 0.43
EPHX1 P07099 1/20 0.43
NR1H4 Q96RI1 1/20 0.42
RAB9A P51151 3/20 0.41
SLC6A2 P23975 1/20 0.41
TRPV1 Q8NER1 4/20 0.41
PDK1 Q15118 1/20 0.41
PDK2 Q15119 1/20 0.41
PDK3 Q15120 1/20 0.41
PDK4 Q16654 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
NPC1 O15118 2/20 0.40
MEN1 O00255 2/20 0.40
HTT P42858 2/20 0.40
KMT2A Q03164 2/20 0.40
MAPT P10636 1/20 0.40
XBP1 P17861 1/20 0.40
MAPK1 P28482 1/20 0.40
KIF11 P52732 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10006033 0.86 PTGER2 (0.41) PTGER2EPHX2EPHX1RAB9ASLC6A2
SCHEMBL10298928 0.83 TSHR (0.46) PTGER2RAB9ASLC6A2SMN1; SMN2NPC1
SCHEMBL9941228 0.79 PTGER2 (0.44) PTGER2EPHX2RAB9ASLC6A2NPC1
SCHEMBL10281189 0.77 KDM1A (0.46)
SCHEMBL10006223 0.76 PTGER2 (0.40) PTGER2NR1H4RAB9ASLC6A2SMN1; SMN2
SCHEMBL2090691 0.76 NR1H4 (0.65) EPHX2NR1H4RAB9ATRPV1PDK1
SCHEMBL19712567 0.71 NR1H4 (0.49) EPHX2EPHX1NR1H4RAB9ATRPV1
SCHEMBL10697564 0.70 PTGER2 (0.40) PTGER2SLC6A2GAA
SCHEMBL10298882 0.69 SLC6A3 (0.41) SLC6A2MEN1KMT2ALMNA
SCHEMBL9938540 0.68 KIF11 (0.49) EPHX2EPHX1NR1H4RAB9ASLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103354808-B Antiviral compound ABBVIE 公司 2016-08-10 CN disclosed
EP-2651885-A1 ANTI-VIRAL COMPOUNDS Abbvie Inc. (US) 2013-10-23 EP disclosed
CN-103354808-A Anti-viral compounds ABBVIE INC 2013-10-16 CN disclosed
WO-2012083170-A1 ANTI-VIRAL COMPOUNDS ABBOTT LABORATORIES (US) 2012-06-21 WO disclosed